According to Technavio, the Molecular Diagnostics Market will grow by USD 7.92 billion, at a CAGR of 5.84% from 2023 to 2028. Key drivers include the rising prevalence of age-related conditions, adoption of innovative treatment methods, and demand from emerging economies. Molecular diagnostics, which examine DNA, RNA, and other molecular markers, are essential for detecting and monitoring diseases such as cancer and infections. The collaboration between synthetic biology and molecular diagnostics is leading to enhanced accuracy in disease detection and the development of personalized healthcare solutions, fueling market expansion.

Click here to download Molecular Diagnostics Market Sample PDF Click here to Contact us for more Information